Sanofi announces $396m vaccine manufacturing facility in Toronto

(adsbygoogle = window.adsbygoogle || []).push({}); French pharma company Sanofi has announced a new vaccine manufacturing facility in Toronto to be built with an investment of CAD500 million ($396.3 million) at the Canadian headquarters of its vaccine business unit Sanofi Pasteur. Sanofi says that the investment in the new vaccine manufacturing More...

by businessnewstoday | Published 8 months ago
By businessnewstoday On Saturday, April 14th, 2018

Alexion to acquire Swedish pharma company Wilson Therapeutics for $855m

Pharma acquisition news : US-based Alexion Pharmaceuticals through an all-cash deal of SEK7.1 billion ($855 million) will acquire Wilson Therapeutics, a Swedish pharma company focused on developing drugs for rare More...

By businessnewstoday On Saturday, April 14th, 2018

GSK offloads rare disease gene therapy drugs to Orchard Therapeutics

Pharma acquisition news : British drug company GlaxoSmithKline (GSK) has agreed to transfer its rare disease gene therapy drugs to Orchard Therapeutics for an equity stake of 19.9% and a seat on the board of the More...

By businessnewstoday On Monday, April 9th, 2018

Novartis to buy US gene therapy company AveXis for $8.7bn

Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion deal to acquire US gene therapy company AveXis in a move to bolster its gene therapy and neuroscience pipeline. Novartis Acquisition More...

By businessnewstoday On Wednesday, March 28th, 2018

GSK to buy out Novartis’ stake in consumer healthcare JV for $13bn

Pharma acquisition news : GlaxoSmithKline (GSK) has agreed to buy out Swiss pharma company Novartis’ stake of 36.5% in their consumer healthcare joint venture (JV) for a price of $13 billion, just days after pulling More...

By businessnewstoday On Saturday, March 24th, 2018

GSK, Reckitt Benckiser pull out from $20bn race to acquire Pfizer’s consumer healthcare business

Pharma acquisition news : In a blow to Pfizer’s plans to offload its consumer healthcare business for about $20 billion, both Reckitt Benckiser and now GlaxoSmithKline (GSK) have pulled out from potential acquisition More...

By businessnewstoday On Friday, March 16th, 2018

Danish pharma company Lundbeck to buy Parkinson’s drug developer Prexton

Pharma acquisition news : Danish pharma company Lundbeck has reached an agreement, expected to be worth around $1.1 billion, to acquire Prexton Therapeutics, a Swiss pharma company focused on Parkinson’s drug More...

By businessnewstoday On Monday, March 12th, 2018

Biogen to acquire Pfizer neurology drug in a deal that could reach $600m

Pharma acquisition news : US biotechnology company Biogen has made a deal with Pfizer to buy the latter’s neurology drug candidate PF-04958242, which is being developed for the treatment of a symptom associated More...

By businessnewstoday On Thursday, February 22nd, 2018

US pharma giant Merck to buy Australian biotech company Viralytics for $394m

Merck acquisition of Viralytics : US pharma giant Merck has made an AUD 502 million ($394 million) deal to acquire Viralytics, an Australian biotech company focused on developing oncolytic immunotherapy treatments More...

By businessnewstoday On Sunday, February 18th, 2018

HECL to distribute Cardax astaxanthin dietary supplement ZanthoSyn in China

Cardax, a Hawaii-based pharma company has inked a purchase agreement with Hong Kong-based Health Elite Club (HECL) for distribution of ZanthoSyn, its astaxanthin dietary supplement for inflammatory health and longevity, More...